KINNATE BIOPHARMA INC

CUSIP: 49705R105 Class: Common Stock

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 91,300 Value ($000) $216 Avg Close — Range —
Q3 2023
Shares 144,300 Value ($000) $202 Avg Close — Range —